GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TerrAscend Corp (FRA:TED) » Definitions » Other Net Income (Loss)

TerrAscend (FRA:TED) Other Net Income (Loss) : €4.1 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is TerrAscend Other Net Income (Loss)?

TerrAscend's Other Net Income (Loss) for the three months ended in Sep. 2024 was €-0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 was €4.1 Mil.

TerrAscend's quarterly Other Net Income (Loss) stayed the same from Mar. 2024 (€0.0 Mil) to Jun. 2024 (€0.0 Mil) but then declined from Jun. 2024 (€0.0 Mil) to Sep. 2024 (€-0.0 Mil).

TerrAscend's annual Other Net Income (Loss) increased from Dec. 2021 (€0.0 Mil) to Dec. 2022 (€0.0 Mil) but then declined from Dec. 2022 (€0.0 Mil) to Dec. 2023 (€-0.0 Mil).


TerrAscend Other Net Income (Loss) Historical Data

The historical data trend for TerrAscend's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TerrAscend Other Net Income (Loss) Chart

TerrAscend Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Net Income (Loss)
Get a 7-Day Free Trial - -24.72 - - -

TerrAscend Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.22 4.08 - - -

TerrAscend Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TerrAscend Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of TerrAscend's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


TerrAscend Business Description

Traded in Other Exchanges
Address
77 City Centre Drive, Suite 501, East Tower, Mississauga, ON, CAN, L5B 1M5
TerrAscend Corp is a company focused on creating and delivering quality cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. It has one operating segment, being cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States.

TerrAscend Headlines

No Headlines